生命科学资讯

Adaptations of the axon initial segment in fast-spiking interneurons of the human neocortex support low action potential thresholds

New recombinant strain of mpox virus identified in the UK

Solving the AAV Titer Challenge: A New Approach to Gene Therapy Workflows

#SABCS25: Roche’s breast cancer pill cuts post-surgery disease recurrence risk by 30%

Roche links oral SERD to 30% breast cancer risk reduction in phase 3 adjuvant trial - Fierce Biotech

Will 2026 be pharma’s M&A breakout year?

Another genetic testing company? Why a different approach could boost drug predictions and R&D.

Prelude Therapeutics divulges new JAK2 inhibitors

Amgen describes new GTPase KRAS mutant inhibitors

New CDK2 and CDK4 degradation inducers disclosed in Nikang Therapeutics patent

Immuse Therapeutics discovers new LRRK2 inhibitors

PsiThera gets $47.5M for oral I&I drugs after spinning out from Roivant

Formation Bio signs deal for TYK2 drug from China's Lynk

A former Roivant spinout bets on AI-designed drugs for immune conditions

UK lowers new medicine rebate scheme to 14.5% for 2026

D3 Bio raises $108M to take next-gen KRAS G12C drug into Phase 3

BlossomHill gets another $84M for macrocyclic approach to EGFR

Cytiva and Fida Biosystems Combine Technologies to Expand Protein Analysis - Genetic Engineering and Biotechnology News

Thermo Fisher Scientific on the value of an integrated approach to drug development - Pharmaphorum

Cytiva and Fida Biosystems collaborate to improve molecular insight for faster drug discovery - BioSpectrum Asia